SABCS 2021: Samuraciclib Shows Preliminary Signs of Activity in Advanced HR-Positive Breast Cancer
Patients with liver metastases and TP53 mutant disease did not benefit
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.